Welcome to Jordanian Association of Pharmaceutical Manufacturers | Jordanian Association of Pharmaceutical Manufacturers

.

GCC Regulatory Affairs Summit 2026 Event Name: GCC Regulatory Affairs Summit Dates: 20 – 24 April 2026 Venue: Mövenpick Grand Al Bustan, Dubai, United Arab Emirates About the Event: The GCC Regulatory Affairs Summit 2026 is the region’s leading platform for regulatory professionals, pharmaceutical leaders, and government authorities to exchange insights on regulatory frameworks, compliance, pharmacovigilance, quality, and market access across the GCC. Now in its 11th edition, the summit continues to support regulatory excellence, collaboration, and innovation in the pharmaceutical sector. Summit Week Structure & Key Events: GCC Regulatory Affairs Pharma Summit 20 – 21 April 2026 Focused on regulatory updates, policy alignment, compliance strategies, and regional regulatory developments. GCC Pharmacovigilance Training 22 – 23 April 2026 Practical training on drug safety systems, adverse event reporting, and PV regulatory requirements. GCC Quality Conference 24 April 2026 Dedicated to pharmaceutical quality management, inspection readiness, and compliance excellence. Register now, on our website: www.pramagcc.com

.

Dr. Hanan Sboul, Secretary General of the Jordanian Association of Pharmaceutical Manufacturers, has made history as the first woman and first non-American elected president of the United States Pharmacopeia (USP). Her five-year term began following a global conference in the U.S. attended by over 400 members from 42 countries.

Founded in 1820, the USP sets pharmaceutical standards in the U.S. and serves as a global reference used in over 150 countries to ensure medicine quality and safety. Dr Hanan election highlights the international recognition of her expertise and marks a proud milestone for Jordan and the Arab pharmaceutical sector.

.

Biosimilars LatAm – Global 2026: Connecting Latin America’s opportunities with the world.

Latin America is gaining unprecedented visibility in the global biosimilars landscape, and Biosimilars LatAm – Global 2026 is where that momentum takes center stage.

This international forum, organized by @Jack-Leckerman, brings together global C-level executives, industry leaders, innovators, and regulators to explore new pathways for collaboration, regulatory alignment, and sustainable access to biotherapeutics.

After more than a decade of successful editions across the region, Biosimilars LatAm – Global continues to serve as the meeting point for decision-makers shaping the future of biosimilars — now on a truly global scale.

📅 Online Forum on February 24 & 25, 2026

🔗 https://jackleckerman.com/events/biosimilars-latam-global-2026/

#BiosimilarsLatAm #Biosimilars #Pharma #Biopharma #LifeSciences #HealthcareInnovation #AccessToMedicines #MarketAccess #RegulatoryAffairs #HealthPolicy #LatinAmerica #GlobalHealth #PharmaIndustry #PharmaEvents